Y Combinator has removed India's Medobed from its S23 batch after discovering irregularities, according to reports. Y Combinator has severed ties with Medobed and advised potential investors against engaging with the medicine delivery startup. An anonymous investor had reportedly raised concerns about Medobed Founder Piyush Sharma altering his educational history and Medobed's growth metrics.